News
Simple exercise equipment works as well as high-tech gym programs for older adults with lung disease
A new study offers encouraging news for older adults with chronic respiratory conditions who may struggle to access traditional gym-based rehabilitation programs. Researchers found that pulmonary ...
Artificial intelligence is showing promise in improving the detection and management of idiopathic pulmonary fibrosis (IPF), ...
For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration (FDA) has ...
In its second-quarter earnings release, the company said that in July and August 2025 it analyzed interim data from the ...
Everyday Health on MSN9h
How to Manage Your Risk of Autoimmune Disease When You Have Primary Immunodeficiency
Learn how to manage your risk of autoimmune disease with primary immunodeficiency. Understand risks, symptoms, and steps to ...
Consistently tracking KL-6 levels may help predict acute exacerbations in IPF and other types of fibrotic ILDs, a study ...
The FDA has approved Insmed’s brensocatib, the first treatment for non-cystic fibrosis bronchiectasis, a chronic and progressive lung disease affecting about 500,000 people in the U.S. The drug was ...
The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...
In an increasingly challenging environment for scientific research funding, the American Lung Association Research Institute today announced the opening of its 2026-2027 Research Awards and Grants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback